Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.

Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.

Item
http://www.wikidata.org/entity/Q33594324
Molecular biology of lung cancerOptimizing the management of advanced non-small-cell lung cancer: a personal viewEGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidenceInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaTargeted Therapies in Lung Cancer.Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts.Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts.Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classificationImaging of lung cancer in the era of molecular medicineClinicopathologic and molecular characteristics of lung adenocarcinoma arising in young patients.Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutationClinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44+CD24- stemness.Guideline Recommendations for EGFR Mutation Testing in Lung Cancer: Proposal of the Korean Cardiopulmonary Pathology Study GroupAssessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.
P2860

Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.

Item
http://www.wikidata.org/entity/Q33594324
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Morphologic features of adenoc ...... itors erlotinib and gefitinib.
@ast
Morphologic features of adenoc ...... itors erlotinib and gefitinib.
@en
type
label
Morphologic features of adenoc ...... itors erlotinib and gefitinib.
@ast
Morphologic features of adenoc ...... itors erlotinib and gefitinib.
@en
prefLabel
Morphologic features of adenoc ...... itors erlotinib and gefitinib.
@ast
Morphologic features of adenoc ...... itors erlotinib and gefitinib.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Morphologic features of adenoc ...... itors erlotinib and gefitinib.
@en
P2093
P2860
P304
P31
P356
10.1043/1543-2165-133.3.470
P433
P478
P50
P577
P698
P921
P932